000			01325 a2200397 4500
005			20250513230352.0
264		0	_c20010405
008			200104s 0 0 eng d
022			_a0012-3692
024	7		_a10.1378/chest.119.1_suppl.194s _2doi
040			_aNLM _beng _cNLM
100	1		_aAlbers, G W
245	0	0	_aAntithrombotic therapy in atrial fibrillation. _h[electronic resource]
260			_bChest _cJan 2001
300			_a194S-206S p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdministration, Oral
650	0	4	_aAged
650	0	4	_aAspirin _xtherapeutic use
650	0	4	_aAtrial Fibrillation _xcomplications
650	0	4	_aElectric Countershock
650	0	4	_aFibrinolytic Agents _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aIntracranial Hemorrhages _xepidemiology
650	0	4	_aOutcome Assessment, Health Care
650	0	4	_aPlatelet Aggregation Inhibitors _xtherapeutic use
650	0	4	_aRisk Assessment
650	0	4	_aStroke _xprevention & control
700	1		_aDalen, J E
700	1		_aLaupacis, A
700	1		_aManning, W J
700	1		_aPetersen, P
700	1		_aSinger, D E
773	0		_tChest _gvol. 119 _gno. 1 Suppl _gp. 194S-206S
856	4	0	_uhttps://doi.org/10.1378/chest.119.1_suppl.194s _zAvailable from publisher's website
999			_c11097241 _d11097241